Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

723
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
723
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

287
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
287
Dementia01:30

Dementia

209
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
209
Protein Networks02:26

Protein Networks

4.1K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
4.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Structured Computational Roadmap for Lipidomics in R: Reproducible Workflows from Raw Data to Functional Insight.

Metabolites·2026
Same author

Human-in-the-Loop Artificial Intelligence: A Systematic Review of Concepts, Methods, and Applications.

Entropy (Basel, Switzerland)·2026
Same author

CpGene: a web application for epigenetic signature identification from DNA methylation arrays.

Bioinformatics (Oxford, England)·2026
Same author

Merging multimodal digital biomarkers into "Digital Neuro Fingerprints" for precision neurology in dementias: the promise of the right treatment for the right patient at the right time in the age of AI.

Frontiers in digital health·2026
Same author

AI agents in Alzheimer's disease management: challenges and future directions.

Frontiers in aging neuroscience·2026
Same author

Artificial intelligence analysis of minimally invasive surgery data.

Journal of robotic surgery·2026

Related Experiment Video

Updated: Oct 8, 2025

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.3K

Handling the Cellular Complex Systems in Alzheimer's Disease Through a Graph Mining Approach.

Aristidis G Vrahatis1, Panagiotis Vlamos2, Maria Gonidi2

  • 1Department of Informatics, Ionian University, Corfu, Greece. arisvrahatis@uth.gr.

Advances in Experimental Medicine and Biology
|January 1, 2022
PubMed
Summary

This study introduces a novel subpathway analysis for single-cell RNA sequencing data to identify perturbed biological processes in diseases like Alzheimer's. The method effectively tracks microglia activation in neurodegeneration, revealing key disease-associated pathways.

Keywords:
Alzheimer’s diseaseComplex systemsPathway analysis

More Related Videos

Application of Granger Causality Analysis of the Directed Functional Connection in Alzheimer's Disease and Mild Cognitive Impairment
08:43

Application of Granger Causality Analysis of the Directed Functional Connection in Alzheimer's Disease and Mild Cognitive Impairment

Published on: August 7, 2017

8.0K
Author Spotlight: Exploring Sex-Specific Glial Signatures and Therapeutic Leads for Alzheimer's Disease
04:22

Author Spotlight: Exploring Sex-Specific Glial Signatures and Therapeutic Leads for Alzheimer's Disease

Published on: May 20, 2024

1.0K

Related Experiment Videos

Last Updated: Oct 8, 2025

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.3K
Application of Granger Causality Analysis of the Directed Functional Connection in Alzheimer's Disease and Mild Cognitive Impairment
08:43

Application of Granger Causality Analysis of the Directed Functional Connection in Alzheimer's Disease and Mild Cognitive Impairment

Published on: August 7, 2017

8.0K
Author Spotlight: Exploring Sex-Specific Glial Signatures and Therapeutic Leads for Alzheimer's Disease
04:22

Author Spotlight: Exploring Sex-Specific Glial Signatures and Therapeutic Leads for Alzheimer's Disease

Published on: May 20, 2024

1.0K

Area of Science:

  • Biomedical Sciences
  • Systems Biology
  • Computational Biology

Background:

  • Medical sciences increasingly rely on advanced biomedical technology and research for understanding complex diseases.
  • Systems biology and pathway analysis are crucial for interpreting high-throughput omics data.
  • Omics technologies generate vast amounts of biological data, necessitating sophisticated analytical tools.

Purpose of the Study:

  • To develop a subpathway analysis method for single-cell RNA sequencing (scRNA-seq) experiments.
  • To identify differentially expressed subpathways indicative of perturbed biological processes in diseases.
  • To apply and validate the method for tracking microglia activation in neurodegeneration.

Main Methods:

  • Developed a novel subpathway analysis approach for scRNA-seq data.
  • Integrated multiple RNA-seq differential expression analysis tools to determine gene differential expression status.
  • Utilized graph mining techniques to analyze pathway complexity.
  • Applied the method to a scRNA-seq dataset for temporal tracking of microglia activation.

Main Results:

  • The developed method successfully isolates differentially expressed subpathways.
  • Consensus-based differential expression analysis minimizes false discoveries.
  • The approach effectively identified perturbed biological processes associated with neurodegeneration in microglia activation data.
  • Demonstrated efficacy on a real-world scRNA-seq dataset.

Conclusions:

  • The subpathway analysis method provides a robust approach for dissecting complex biological systems from scRNA-seq data.
  • This method aids in understanding disease pathogenesis by pinpointing specific perturbed pathways.
  • The findings highlight the potential of systems biology tools in neurodegeneration research and disease diagnostics.